The synthesis of glycolipopeptide cancer vaccine candidate by native chemical ligation

CARB 41

Sampat Ingale, singale@chem.uga.edu, Therese Buskas, tbuskas@ccrc.uga.edu, and Geert-Jan Boons, gjboons@ccrc.uga.edu. Complex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, Athens, GA 30602
A novel synthetic methodology has been developed for the construction of a three-component synthetic anti-cancer vaccine candidate by native chemical ligation. The vaccine candidate constitutes the minimal structural features required for an effective T-cell dependent immune response and is composed of a carbohydrate B-epitope, a peptide T-epitope and a lipopeptide adjuvant. Lipidation of the antigen facilitated the incorporation into liposomes, which in turn improved the presentation of the immunogen to the immune system. Immunological properties of the liposomes have been studied.
 

General Posters
6:00 PM-8:00 PM, Tuesday, 28 March 2006 Georgia World Congress Center -- Ex. Hall B4, Poster

Division of Carbohydrate Chemistry

The 231st ACS National Meeting, Atlanta, GA, March 26-30, 2006